Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.050
-0.030 (-2.78%)
Sep 5, 2025, 4:00 PM - Market closed
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $38.92 million as of September 5, 2025. Its market cap has decreased by -22.47% in one year.
Market Cap
38.92M
Enterprise Value
37.61M
1-Year Change
-22.47%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $38.92M, an increase of 2,089.41%. That is a compound annual growth rate of 191.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 38.92M | -10.36% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |